C-level executives from eight biotechnology companies will discuss their plans to invent, develop, research, and market important new drugs, diagnostics, and delivery technologies at the New York Society of Security Analysts’ 14th Annual Biotech and Specialty Pharma Conference on November 30, 2010. The companies’ developments range from oncology to dermatology therapies. George Fulop, MD, managing director at Stuyvesant Capital Management, will discuss the outlook for the biotech and specialty pharma industry.

After a strong recovery in 2009, investment performance in the biotech industry is mixed these days, with small-cap companies generally outperforming the large-cap stocks. The NASDAQ Biotechnology Index (NBI), the broadest measure of biotech sector performance, is essentially flat for the year compared to a 1% drop in the S&P 500. The Amex Biotechnology Index (BTK) is up 18% for the year. M&A activity is expected to rise in the coming years due to stunted growth in the big pharma market, which is projected to hold at 5–8% through 2014 because of drugs that are coming off patent and will be facing generic competition.

Some of the most innovative small- and micro-cap companies will present at the conference:

  • ADVENTRX Pharmaceuticals, Inc. (NYSE, AMEX: ANX)
  • Anika Therapeutics, Inc. (NASDAQ: ANIK)
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)
  • DARA BioSciences, Inc. (NASDAQ: DARA)
  • EpiCept Corporation (NASDAQ: EPTC)
  • GenSpera, Inc. (OTCBB: GNSZ)
  • Polymedix, Inc. (NYSE: PYMX)
  • Provectus Pharmaceuticals, Inc (OTC: PVCT)
  • Senesco (NYSE, AMEX: SNT)
  • SuperGen (NASDAQ: SUPG)

The full-day conference will be held on November 30, 2010 from 8:30 a.m.–4:40 p.m. at 1540 Broadway, Suite 1010, New York, NY 10036.

For more information on the conference, please visit: www.nyssa.org/biotech.

There is no charge for press with credentials.

About NYSSA

The New York Society of Security Analysts (NYSSA) is a leading forum for the investment community. NYSSA’s mission is to promote best practices and the highest professional and ethical standards in the industry. With over 10,000 members, NYSSA is the largest of the 135 societies worldwide that make up CFA Institute, which has more than 100,000 members.

Adventrx (AMEX:ANX)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Adventrx Charts.
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Adventrx Charts.